Plasma immune markers in an idiopathic REM sleep behavior disorder cohort

• Published in: Parkinsonism & related disorders Vol. 78; pp. 145 - 150
• Main Authors: Zhang, Hui, Wang, Ting, Li, Yuan, Mao, Wei, Hao, Shuwen, Huang, Zhaoyang, Chan, Piu, Cai, Yanning
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.09.2020
• Subjects: Biomarker; Cytokines; IL-10; iRBD; TNF-α; Biomarker; iRBD; Cytokines; TNF-α; IL-10
• ISSN: 1353-8020; 1873-5126
• DOI: 10.1016/j.parkreldis.2020.07.017

Increasing evidence shows a strong association between idiopathic REM sleep behavior disorder (iRBD) and α-synucleinopathies. Recent studies have indicated an inflammatory mechanism in the pathogenesis of α-synucleinopathies. Whether peripheral inflammatory cytokines are altered in iRBD and can be biomarkers for predicting phenoconversion remains unclear. We collected baseline plasma samples from 77 consecutive iRBD patients and 64 age- and sex-matched healthy controls. Ten cytokines were measured: Interferon (IFN)-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, and tumor necrosis factor (TNF)-α. All iRBD patients underwent clinical assessment tests at baseline, and 75 were prospectively followed and received assessments for parkinsonism or dementia. Cox regression analyses were used to evaluate the predictive value of plasma cytokines in a follow-up period of 6.0 years. TNF-α and IL-10 were significantly elevated in iRBD compared with controls (both p < 0.001). IL-6/IL-10 and IL-8/IL-10 were significantly reduced in iRBD than in controls (p = 0.001, p < 0.001, respectively). After a median follow-up of 3.7 years, 16 iRBD patients developed neurodegenerative synucleinopathies. iRBD patients with higher TNF-α/IL-10 levels were more likely to develop neurodegenerative diseases (adjusted HR 1.07, 95% CI 1.01–1.14). The coexistence of elevated TNF-α/IL-10 and possible mild cognitive impairment predicted an early conversion of iRBD to neurodegenerative synucleinopathies (adjusted HR 4.17, 95% CI 1.47–11.81). Our study supported the early involvement of peripheral inflammation in prodromal α-synucleinopathy. Plasma cytokines may be predictive of disease conversion in iRBD, while large-scale longitudinal studies are warranted to validate the assumption. •Plasma TNF-α and IL-10 were upregulated in patients with idiopathic RBD (iRBD).•TNF-α, IL-10, IL-6/IL-10, and IL-8/IL-10 may be useful markers for identifying iRBD.•iRBD with higher TNF-α/IL-10 levels were more likely to develop α-synucleinopathies.•Coexistence of elevated TNF-α/IL-10 and possible mild cognitive impairment predicted iRBD phenoconversion.